Surgical Historical Income Statement

0AAU Stock   149.50  0.10  0.07%   
Historical analysis of Surgical Science income statement accounts such as Ebit of 196.6 M, Net Income Applicable To Common Shares of 227 M or Income Tax Expense of 24.4 M can show how well Surgical Science Sweden performed in making a profits. Evaluating Surgical Science income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Surgical Science's future profits or losses.

Surgical Science Net Income

118.01 Million

  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Surgical Science Sweden. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Surgical Income Statement Analysis

Surgical Science Sweden Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Surgical Science shareholders. The income statement also shows Surgical investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Surgical Science Income Statement Chart

EBIT is likely to gain to about 196.6 M in 2024. Net Income Applicable To Common Shares is likely to gain to about 227 M in 2024

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Surgical Science Sweden. It is also known as Surgical Science overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.
Most accounts from Surgical Science's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Surgical Science Sweden current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Surgical Science Sweden. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
EBIT is likely to gain to about 196.6 M in 2024. Net Income Applicable To Common Shares is likely to gain to about 227 M in 2024
 2023 2024 (projected)
EBIT187.3M196.6M
Other Operating Expenses599.4K532.8K

Surgical Science income statement Correlations

Surgical Science Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Surgical Stock Analysis

When running Surgical Science's price analysis, check to measure Surgical Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgical Science is operating at the current time. Most of Surgical Science's value examination focuses on studying past and present price action to predict the probability of Surgical Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgical Science's price. Additionally, you may evaluate how the addition of Surgical Science to your portfolios can decrease your overall portfolio volatility.